![Kenneth Moch](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kenneth Moch
Direttore/Membro del Consiglio presso
Gamida Cell, Inc.
Profilo
Kenneth I.
Moch was the founder of The Liposome Co., Inc. (founded in 1982) where he served as Vice President from 1982 to 1988.
He also founded Synvista Therapeutics, Inc. in 1995, where he held the titles of Chairman, President & Chief Executive Officer until 2006.
In 2008, Mr. Moch founded BioMedical Enterprises, Inc. and served as President & Chief Executive Officer until 2009.
He also founded PharmaStem Therapeutics, Inc. in 1990 and served as President & Chief Executive Officer until 1995.
In 2016, Mr. Moch founded Cognition Therapeutics, Inc. and held the titles of President, Chief Executive Officer & Director until 2020.
Mr. Moch's former jobs include serving as President, Chief Executive Officer & Director of Chimerix, Inc. from 2009 to 2014.
He was also President & Chief Executive Officer of BioMedical Enterprises, Inc. from 2008 to 2009.
Additionally, Mr. Moch served as President & Chief Executive Officer of PharmaStem Therapeutics, Inc. from 1990 to 1995.
He was the President of Euclidean Life Science Advisors LLC from 2014 to 2015 and the Managing Partner of Salutramed Group LLC from 2015 to 2016.
Mr. Moch's education includes an undergraduate degree from Princeton University and an undergraduate degree from the Graduate School of Business.
Posizioni attive di Kenneth Moch
| Società | Posizione | Inizio |
|---|---|---|
Gamida Cell, Inc.
 Gamida Cell, Inc. BiotechnologyHealth Technology Develops cellular and immune therapeutics | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Kenneth Moch
| Società | Posizione | Fine |
|---|---|---|
| GAMIDA CELL LTD. | Direttore/Membro del Consiglio | 24/05/2024 |
| ZYNERBA PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 10/10/2023 |
| COGNITION THERAPEUTICS, INC. | Amministratore Delegato | 27/03/2020 |
Salutramed Group LLC | Corporate Officer/Principal | 01/10/2016 |
Euclidean Life Science Advisors LLC
 Euclidean Life Science Advisors LLC Miscellaneous Commercial ServicesCommercial Services Provides life science advisory services | Presidente | 01/09/2015 |
Formazione di Kenneth Moch
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
58
Relazioni di 1° grado
19
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 19 |
|---|---|
Synvista Therapeutics, Inc.
 Synvista Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for diseases of cardiovascular aging and diabetes complications | Health Technology |
Emisphere Technologies, Inc.
 Emisphere Technologies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial stage pharmaceutical and drug delivery company | Health Technology |
The Liposome Co., Inc.
 The Liposome Co., Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures, and markets therapeutic products to treat cancer and related diseases | Health Technology |
ThinkEquity Partners
 ThinkEquity Partners Investment ManagersFinance Provides investment advice and security brokerage services | Finance |
Chimerix, Inc.
 Chimerix, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines for rare epilepsies, cancers and sleep disorders | Health Technology |
BioMedical Enterprises, Inc.
 BioMedical Enterprises, Inc. Medical SpecialtiesHealth Technology Designs, manufactures and markets memory metal implants | Health Technology |
Catalyst Ventures, Inc.
 Catalyst Ventures, Inc. Investment ManagersFinance Catalyst Ventures invests in companies located in US. The firm targets companies operating in the fields of health technology, medical specialties. | Finance |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Zynerba Pharmaceuticals, Inc.
 Zynerba Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Delivers dermal solutions for the treatment of neuroscience disorders | Health Technology |
Princeton University
 Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PharmaStem Therapeutics, Inc.
 PharmaStem Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops umbilical cord and placental blood preservation drugs | Health Technology |
Gamida Cell Ltd.
 Gamida Cell Ltd. Pharmaceuticals: MajorHealth Technology Engages in the development of cell therapies to cure blood cancer and rare serious hematologic diseases | Health Technology |
Cognition Therapeutics, Inc.
 Cognition Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage neuroscience company that develops drugs to help restore normal cellular damage responses in neurodegenerative and neuro-ophthalmic disorders | Health Technology |
BioNJ, Inc.
 BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services Promotes the biotechnology industry in New Jersey | Commercial Services |
Aster Insights
 Aster Insights Miscellaneous Commercial ServicesCommercial Services Provides scientific and clinical intelligence solutions for oncology drug discovery | Commercial Services |
Graduate School of Business
 Graduate School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Euclidean Life Science Advisors LLC
Euclidean Life Science Advisors LLC Miscellaneous Commercial ServicesCommercial Services Provides life science advisory services | Commercial Services |
Salutramed Group LLC | |
Gamida Cell, Inc.
Gamida Cell, Inc. BiotechnologyHealth Technology Develops cellular and immune therapeutics | Health Technology |
